RecruitingLiver Diseases
Development of a FibroScan Liver Examination Using a Single Probe
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is an exploratory, international, prospective, interventional, multicenter clinical investigation that will take place in 1 Hong Kong site and 3 French sites and 309 adults patients will be included. The study objective is to assess the LSM reproducibility between the FibroScan examination performed with the Single Probe (SP) and the FibroScan examination performed with the reference probes (M and XL).
Sponsor: Echosens
You may qualify if…
- ✓ Adult patients (≥ 18 years of age).
- ✓ Patient followed with a chronic liver disease.
- ✓ Adult patient able to give his written consent.
- ✓ For European sites: patient affiliated to the healthcare system.
You may not qualify if…
- ✕ Vulnerable patients.
- ✕ Patients with ascites.
- ✕ Patients with heart failure.
- ✕ Patients with acute hepatitis.
- ✕ Patients with biliary obstruction.
Source: ClinicalTrials.gov · NCT07400289 · last updated 2026-02-10